Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 10.5.2016 | EN | Official Journal of the European Union | C 165/16 |

---

Action brought on 18 March 2016 — Laboratoire de la mer v EUIPO — Boehringer Ingelheim Pharma (RESPIMER)

(Case T-109/16)

(2016/C 165/18)

Language in which the application was lodged: English

Parties

Applicant: Laboratoire de la mer (Saint-Malo, France) (represented by: S. Szilvasi, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Boehringer Ingelheim Pharma GmbH & Co. KG (Ingelheim, Germany)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant

Trade mark at issue: EU word mark ‘RESPIMER’ — Application for registration No 11 228 004

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 21 January 2016 in Case R 3109/2014-5

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | allow the EU trade mark application ‘RESPIMER’ No 11 228 004 to mature to registration for all designated goods in classes 3, 5 and 10; |

|  |  |
| --- | --- |
| — | order Boehringer Ingelheim Pharma GmbH & Co. KG to reimburse all costs to the applicant before the Opposition division of the EUIPO, the Fifth Board of Appeal of the EUIPO and the General Court of the European Union. |

Pleas in law

|  |  |
| --- | --- |
| — | By refusing to take into consideration the decision of April 4, 2013 of the French national institute of industrial property as regards the same marks, the fifth board of appeal has failed to provide legal basis to its decision of January 21, 2016; |

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation No 207/2009. |

---

[Top](#document1)